Clinical Trial Update: Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and pharmacodynamics study of GSK461364 in subjects with Non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• GSK461364 (GSK461364)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 1 | Status: COMPLETED